Puromycin Dihydrochloride,Remdesivir,Favipiravir,Ritonavir,Camostat Mesylate,Aloxistatin,Ripa Buffe

By: MINISTRY OF DEFENCE - DEPARTMENT OF DEFENCE RESEARCH & DEVELOPMENT๐Ÿ“ IndiaOpen

Key Information

ReferenceGB-GEM/2026/B/7955092
DeadlineSep 14, 2026 12:00 AM
Competition TypeNCB
Funding SourceSelf-Funded
CountryIndia
AddressCountry: India
PublishedAug 25, 2026

Description

Puromycin Dihydrochloride,Remdesivir,Favipiravir,Ritonavir,Camostat Mesylate,Aloxistatin,Ripa Buffe Quantity: 20 Start Date: 25-08-2026 2:27 PM End Date: 14-09-2026 3:00 PM Ministry of Defence - ...

Full details are available after unlocking this tender.